Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells

Circulation Research

Volumn 87, Issue 7, 2000, Pages 616-622

  Hernández Perera, Octavio ^a,b   Pérez Sala, Dolores ^a   Soria, Estrella ^a   Lamas, Santiago ^a,c  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Cholesterol; Endothelin; Endothelium; GTP binding proteins; Statins

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RHO FACTOR; SIMVASTATIN;

ANIMAL CELL; ARTICLE; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034730781     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.7.616     Document Type: Article

References (36)

1. Cellular and molecular mechanisms of endothelial cell dysfunction
2. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
3. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
4. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
5. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
6. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
7. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
8. Regulation of the mevalonate pathway
9. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins
10. Increasing complexity of Ras signaling
11. Rho GTPases
12. Rho family proteins and Ras transformation: The RHOad less traveled gets congested
13. Endothelin peptides
14. Identification of newly transcribed RNA
15. Structural organization and chromosomal assignment of the gene encoding endothelin
16. Functional analysis of the endothelin-1 gene promoter: Evidence for an endothelial cell-specific cis-acting sequence
17. Transcriptional induction of endothelial nitric oxide gene by cyclosporine A: A role for activator protein-1
18. Effects of interferon-γ on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells
19. Comparison of three actin-coding sequences in the mouse: Evolutionary relationships between the actin genes of warm-blooded vertebrates
20. Analogs of farnesyl-cysteine induce apoptosis in HL-60 cells
21. Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells
22. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1β vascular smooth muscle cells
23. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor
24. Bacterial toxins that target Rho proteins
25. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide
26. Post-translational modifications of p21rho proteins
27. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes
28. Protein prenyltransferases
29. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene
30. The Rho family GTPases RhoA, Racl, and CDC42Hs regulate transcriptional activation by SRF
31. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway
32. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes: Possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy
33. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27 (Kip1)
34. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
35. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells
36. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure